Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years.

(Reuters) - Paris prosecutors opened a criminal probe into Philips in June over its recall of sleep apnea devices, probing possible charges including aggravated fraud and failure to report safety ...

PITTSBURGH — A Pennsylvania federal court remanded a California woman’s negligence complaint over injuries allegedly caused by a recalled Philips CPAP device back to Los Angeles County Superior Court.